{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:55:20Z","timestamp":1771026920950,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900147"],"award-info":[{"award-number":["81900147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32030030"],"award-info":[{"award-number":["32030030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200172"],"award-info":[{"award-number":["82200172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2019YFA0801800"],"award-info":[{"award-number":["2019YFA0801800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13402-024-01003-y","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:02:15Z","timestamp":1729065735000},"page":"411-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["BCAT1 contributes to the development of TKI-resistant CML"],"prefix":"10.1007","volume":"48","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Difan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"5940","key":"1003_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"C.R. Bartram","year":"1983","unstructured":"C.R. Bartram, A. de Klein, A. Hagemeijer, T. van Agthoven, A.G. van Kessel, D. Bootsma, G. Grosveld, M.A. Ferguson-Smith, T. Davies, M. Stone, Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306(5940), 277\u2013280 (1983)","journal-title":"Nature"},{"issue":"23","key":"1003_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"B.J. Druker","year":"2006","unstructured":"B.J. Druker, F. Guilhot, S.G. O\u2019Brien, I. Gathmann, H. Kantarjian, N. Gattermann, M.W.N. Deininger, R.T. Silver, J.M. Goldman, R.M. Stone, F. Cervantes, A. Hochhaus, B.L. Powell, J.L. Gabrilove, P. Rousselot, J. Reiffers, J.J. Cornelissen, T. Hughes, H. Agis, T. Fischer, G. Verhoef, J. Shepherd, G. Saglio, A. Gratwohl, J.L. Nielsen, J.P. Radich, B. Simonsson, K. Taylor, M. Baccarani, C. So, L. Letvak, R.A. Larson, IRIS Investigators, Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355(23), 2408\u20132417 (2006)","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"1003_CR3","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","volume":"26","author":"H. de Lavallade","year":"2008","unstructured":"H. de Lavallade, J.F. Apperley, J.S. Khorashad, D. Milojkovic, A.G. Reid, M. Bua, R. Szydlo, E. Olavarria, J. Kaeda, J.M. Goldman, D. Marin, Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 26(20), 3358\u20133363 (2008)","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"1003_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M. Baccarani","year":"2013","unstructured":"M. Baccarani, M.W. Deininger, G. Rosti, A. Hochhaus, S. Soverini, J.F. Apperley, F. Cervantes, R.E. Clark, J.E. Cortes, F. Guilhot, H. Hjorth-Hansen, T.P. Hughes, H.M. Kantarjian, D.-W. Kim, R.A. Larson, J.H. Lipton, F.-X. Mahon, G. Martinelli, J. Mayer, M.C. M\u00fcller, D. Niederwieser, F. Pane, J.P. Radich, P. Rousselot, G. Saglio, S. Sau\u00dfele, C. Schiffer, R. Silver, B. Simonsson, J.-L. Steegmann, J.M. Goldman, R. Hehlmann, European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122(6), 872\u2013884 (2013)","journal-title":"Blood"},{"issue":"1","key":"1003_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.leukres.2013.09.011","volume":"38","author":"S. Soverini","year":"2014","unstructured":"S. Soverini, S. Branford, F.E. Nicolini, M. Talpaz, M.W.N. Deininger, G. Martinelli, M.C. M\u00fcller, J.P. Radich, N.P. Shah, Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leuk Res. 38(1), 10\u201320 (2014)","journal-title":"Leuk Res."},{"issue":"5486","key":"1003_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","volume":"289","author":"T. Schindler","year":"2000","unstructured":"T. Schindler, W. Bornmann, P. Pellicena, W.T. Miller, B. Clarkson, J. Kuriyan, Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289(5486), 1938\u20131942 (2000)","journal-title":"Science"},{"issue":"15","key":"1003_CR7","first-page":"4236","volume":"62","author":"B. Nagar","year":"2002","unstructured":"B. Nagar, W.G. Bornmann, P. Pellicena, T. Schindler, D.R. Veach, W.T. Miller, B. Clarkson, J. Kuriyan, Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 62(15), 4236\u20134243 (2002)","journal-title":"Cancer Res."},{"issue":"1","key":"1003_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"A.S. Corbin","year":"2011","unstructured":"A.S. Corbin, A. Agarwal, M. Loriaux, J. Cortes, M.W. Deininger, B.J. Druker, Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121(1), 396\u2013409 (2011)","journal-title":"J. Clin. Invest."},{"issue":"1","key":"1003_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"S.M. Graham","year":"2002","unstructured":"S.M. Graham, H.G. J\u00f8rgensen, E. Allan, C. Pearson, M.J. Alcorn, L. Richmond, T.L. Holyoake, Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99(1), 319\u2013325 (2002)","journal-title":"Blood"},{"issue":"5","key":"1003_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/sj.leu.2404609","volume":"21","author":"X. Jiang","year":"2007","unstructured":"X. Jiang, Y. Zhao, C. Smith, M. Gasparetto, A. Turhan, A. Eaves, C. Eaves, Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia 21(5), 926\u2013935 (2007)","journal-title":"Leukemia"},{"issue":"25","key":"1003_CR11","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","volume":"123","author":"H. Herrmann","year":"2014","unstructured":"H. Herrmann, I. Sadovnik, S. Cerny-Reiterer, T. R\u00fclicke, G. Stefanzl, M. Willmann, G. Hoermann, M. Bilban, K. Blatt, S. Herndlhofer, M. Mayerhofer, B. Streubel, W.R. Sperr, T.L. Holyoake, C. Mannhalter, P. Valent, Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood 123(25), 3951\u20133962 (2014)","journal-title":"Blood"},{"issue":"9","key":"1003_CR12","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/stem.1748","volume":"32","author":"F. Pellicano","year":"2014","unstructured":"F. Pellicano, M.T. Scott, G.V. Helgason, L.E.M. Hopcroft, E.K. Allan, M. Aspinall-O\u2019Dea, M. Copland, A. Pierce, B.J.P. Huntly, A.D. Whetton, T.L. Holyoake, The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem. Cells Dayt. Ohio 32(9), 2324\u20132337 (2014)","journal-title":"Stem. Cells Dayt. Ohio"},{"issue":"11","key":"1003_CR13","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1084\/jem.20110304","volume":"208","author":"C. Hurtz","year":"2011","unstructured":"C. Hurtz, K. Hatzi, L. Cerchietti, M. Braig, E. Park, Y. Kim, S. Herzog, P. Ramezani-Rad, H. Jumaa, M.C. M\u00fcller, W.-K. Hofmann, A. Hochhaus, B.H. Ye, A. Agarwal, B.J. Druker, N.P. Shah, A.M. Melnick, M. M\u00fcschen, BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J. Exp. Med. 208(11), 2163\u20132174 (2011)","journal-title":"J. Exp. Med."},{"issue":"1","key":"1003_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","volume":"7","author":"L. Jin","year":"2008","unstructured":"L. Jin, Y. Tabe, S. Konoplev, Y. Xu, C.E. Leysath, H. Lu, S. Kimura, A. Ohsaka, M.-B. Rios, L. Calvert, H. Kantarjian, M. Andreeff, M. Konopleva, CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol. Cancer Ther. 7(1), 48\u201358 (2008)","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"1003_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/2159-8290.CD-15-1439","volume":"6","author":"H. Xie","year":"2016","unstructured":"H. Xie, C. Peng, J. Huang, B.E. Li, W. Kim, E.C. Smith, Y. Fujiwara, J. Qi, G. Cheloni, P.P. Das, M. Nguyen, S. Li, J.E. Bradner, S.H. Orkin, Chronic myelogenous leukemia- initiating cells require polycomb group protein EZH2. Cancer Discov. 6(11), 1237\u20131247 (2016)","journal-title":"Cancer Discov."},{"issue":"12","key":"1003_CR16","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1002\/ctm2.1146","volume":"12","author":"M.A. Gonzalez","year":"2022","unstructured":"M.A. Gonzalez, I.M. Olivas, A.E. Bencomo-Alvarez, A.J. Rubio, C. Barreto-Vargas, J.L. Lopez, S.K. Dang, J.P. Solecki, E. McCall, G. Astudillo, V.V. Velazquez, K. Schenkel, K. Reffell, M. Perkins, N. Nguyen, J.N. Apaflo, E. Alvidrez, J.E. Young, J.J. Lara, D. Yan, A. Senina, J. Ahmann, K.E. Varley, C.C. Mason, C.A. Eide, B.J. Druker, M. Nurunnabi, O. Padilla, S. Bajpeyi, A.M. Eiring, Loss of G0\/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clin. Transl. Med. 12(12), e1146 (2022)","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"1003_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","volume":"8","author":"Y. Wang","year":"2011","unstructured":"Y. Wang, Y. Liu, S.N. Malek, P. Zheng, Y. Liu, Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies. Cell. Stem. Cell. 8(4), 399\u2013411 (2011)","journal-title":"Cell. Stem. Cell."},{"issue":"6","key":"1003_CR18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","volume":"158","author":"Y.-H. Wang","year":"2014","unstructured":"Y.-H. Wang, W.J. Israelsen, D. Lee, V.W.C. Yu, N.T. Jeanson, C.B. Clish, L.C. Cantley, M.G. Vander Heiden, D.T. Scadden, Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell. 158(6), 1309\u20131323 (2014)","journal-title":"Cell."},{"issue":"5","key":"1003_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","volume":"17","author":"Y. Saito","year":"2015","unstructured":"Y. Saito, R.H. Chapple, A. Lin, A. Kitano, D. Nakada, AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell. Stem. Cell. 17(5), 585\u2013596 (2015)","journal-title":"Cell. Stem. Cell."},{"issue":"3","key":"1003_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12032-010-9529-9","volume":"28","author":"L. Liu","year":"2011","unstructured":"L. Liu, R. Chen, S. Huang, Y. Wu, G. Li, Q. Liu, D. Yin, Y. Liang, Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy. Med. Oncol. Northwood Lond. Engl. 28(3), 835\u2013839 (2011)","journal-title":"Med. Oncol. Northwood Lond. Engl."},{"issue":"7","key":"1003_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y. Chen","year":"2009","unstructured":"Y. Chen, Y. Hu, H. Zhang, C. Peng, S. Li, Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet. 41(7), 783\u2013792 (2009)","journal-title":"Nat. Genet."},{"issue":"7655","key":"1003_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A. Hattori","year":"2017","unstructured":"A. Hattori, M. Tsunoda, T. Konuma, M. Kobayashi, T. Nagy, J. Glushka, F. Tayyari, D. McSkimming, N. Kannan, A. Tojo, A.S. Edison, T. Ito, Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature 545(7655), 500\u2013504 (2017)","journal-title":"Nature"},{"issue":"7680","key":"1003_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S. Raffel","year":"2017","unstructured":"S. Raffel, M. Falcone, N. Kneisel, J. Hansson, W. Wang, C. Lutz, L. Bullinger, G. Poschet, Y. Nonnenmacher, A. Barnert, C. Bahr, P. Zeisberger, A. Przybylla, M. Sohn, M. T\u00f6njes, A. Erez, L. Adler, P. Jensen, C. Scholl, S. Fr\u00f6hling, S. Cocciardi, P. Wuchter, C. Thiede, A. Fl\u00f6rcken, J. Westermann, G. Ehninger, P. Lichter, K. Hiller, R. Hell, C. Herrmann, A.D. Ho, J. Krijgsveld, B. Radlwimmer, A. Trumpp, BCAT1 restricts \u03b1KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551(7680), 384\u2013388 (2017)","journal-title":"Nature"},{"issue":"5","key":"1003_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2008.03.002","volume":"7","author":"P. Gulati","year":"2008","unstructured":"P. Gulati, L.D. Gaspers, S.G. Dann, M. Joaquin, T. Nobukuni, F. Natt, S.C. Kozma, A.P. Thomas, G. Thomas, Amino acids activate mTOR complex 1 via Ca2+\/CaM signaling to hVps34. Cell. Metab. 7(5), 456\u2013465 (2008)","journal-title":"Cell. Metab."},{"issue":"2","key":"1003_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/MCB.01285-12","volume":"33","author":"F. Mercan","year":"2013","unstructured":"F. Mercan, H. Lee, S. Kolli, A.M. Bennett, Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling. Mol. Cell. Biol. 33(2), 293\u2013306 (2013)","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"1003_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm1515","volume":"12","author":"K. Sato","year":"2006","unstructured":"K. Sato, A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, Y. Morishita, H. Asahara, K. Ohya, A. Yamaguchi, T. Takai, T. Kodama, T.A. Chatila, H. Bito, H. Takayanagi, Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12(12), 1410\u20131416 (2006)","journal-title":"Nat. Med."},{"issue":"16","key":"1003_CR27","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","volume":"184","author":"X. Guo","year":"2021","unstructured":"X. Guo, J. Zhou, C. Starr, E.J. Mohns, Y. Li, E.P. Chen, Y. Yoon, C.P. Kellner, K. Tanaka, H. Wang, W. Liu, L.R. Pasquale, J.B. Demb, M.C. Crair, B. Chen, Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell. 184(16), 4299\u20134314.e12 (2021)","journal-title":"Cell."},{"issue":"2","key":"1003_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0955-0674(93)90111-3","volume":"5","author":"H. Schulman","year":"1993","unstructured":"H. Schulman, The multifunctional Ca2+\/calmodulin-dependent protein kinases. Curr. Opin. Cell. Biol. 5(2), 247\u2013253 (1993)","journal-title":"Curr. Opin. Cell. Biol."},{"issue":"12","key":"1003_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm1515","volume":"12","author":"K. Sato","year":"2006","unstructured":"K. Sato, A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, Y. Morishita, H. Asahara, K. Ohya, A. Yamaguchi, T. Takai, T. Kodama, T.A. Chatila, H. Bito, H. Takayanagi, Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12(12), 1410\u20131416 (2006)","journal-title":"Nat. Med."},{"issue":"16","key":"1003_CR30","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","volume":"184","author":"X. Guo","year":"2021","unstructured":"X. Guo, J. Zhou, C. Starr, E.J. Mohns, Y. Li, E.P. Chen, Y. Yoon, C.P. Kellner, K. Tanaka, H. Wang, W. Liu, L.R. Pasquale, J.B. Demb, M.C. Crair, B. Chen, Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell. 184(16), 4299\u20134314.e12 (2021)","journal-title":"Cell."},{"issue":"1","key":"1003_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","volume":"175","author":"S.K. McBrayer","year":"2018","unstructured":"S.K. McBrayer, J.R. Mayers, G.J. DiNatale, D.D. Shi, J. Khanal, A.A. Chakraborty, K.A. Sarosiek, K.J. Briggs, A.K. Robbins, T. Sewastianik, S.J. Shareef, B.A. Olenchock, S.J. Parker, K. Tateishi, J.B. Spinelli, M. Islam, M.C. Haigis, R.E. Looper, K.L. Ligon, B.E. Bernstein, R.D. Carrasco, D.P. Cahill, J.M. Asara, C.M. Metallo, N.H. Yennawar, M.G. Vander Heiden, K. W.G. Jr, Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in Glioma. Cell. 175(1), 101\u2013116.e25 (2018)","journal-title":"Cell."},{"issue":"6","key":"1003_CR32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2023.05.007","volume":"30","author":"L. Beziaud","year":"2023","unstructured":"L. Beziaud, C.M. Young, A.M. Alonso, M. Norkin, A.R. Minafra, J. Huelsken, IFN\u03b3-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy. Cell. Stem. Cell. 30(6), 818\u2013831.e6 (2023)","journal-title":"Cell. Stem. Cell."},{"issue":"3","key":"1003_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ygyno.2022.03.018","volume":"165","author":"L.M. Marinelli","year":"2022","unstructured":"L.M. Marinelli, J.B. Kisiel, S.W. Slettedahl, D.W. Mahoney, M.A. Lemens, V. Shridhar, W.R. Taylor, J.K. Staub, X. Cao, P.H. Foote, K.N. Burger, C.K. Berger, M.C. O\u2019Connell, K.A. Doering, M. Giakoumopoulos, H. Berg, C. Volkmann, A. Solsrud, H.T. Allawi, M. Kaiser, A.M. Vaccaro, C. Albright Crawford, C. Moehlenkamp, G. Shea, M.S. Deist, J.K. Schoolmeester, S.E. Kerr, M.E. Sherman, J.N. Bakkum-Gamez, Methylated DNA markers for plasma detection of ovarian cancer: discovery, validation, and clinical feasibility. Gynecol. Oncol. 165(3), 568\u2013576 (2022)","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"1003_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L. Han","year":"2023","unstructured":"L. Han, L. Dong, K. Leung, Z. Zhao, Y. Li, L. Gao, Z. Chen, J. Xue, Y. Qing, W. Li, S.P. Pokharel, M. Gao, M. Chen, C. Shen, B. Tan, A. Small, K. Wang, Z. Zhang, X. Qin, L. Yang, M. Wunderlich, B. Zhang, J.C. Mulloy, G. Marcucci, C.W. Chen, M. Wei, R. Su, J. Chen, X. Deng, METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell. Stem. Cell. 30(1), 52\u201368.e13 (2023)","journal-title":"Cell. Stem. Cell."},{"key":"1003_CR35","doi-asserted-by":"crossref","unstructured":"Y.H. Zheng, W.J. Hu, B.C. Chen, T.H. Grahn, Y.R. Zhao, H.L. Bao, Y.F. Zhu, Q.Y. Zhang, Liver Int. 36, 1836\u20131847 (2016)","DOI":"10.1111\/liv.13178"},{"issue":"6","key":"1003_CR36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2023.05.007","volume":"30","author":"L. Beziaud","year":"2023","unstructured":"L. Beziaud, C.M. Young, A.M. Alonso, M. Norkin, A.R. Minafra, J. Huelsken, IFN\u03b3-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy. Cell. Stem. Cell. 30(6), 818\u2013831.e6 (2023)","journal-title":"Cell. Stem. Cell."},{"issue":"13","key":"1003_CR37","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-21-3868","volume":"82","author":"B. Zhang","year":"2022","unstructured":"B. Zhang, H. Peng, M. Zhou, L. Bao, C. Wang, F. Cai, H. Zhang, J.E. Wang, Y. Niu, Y. Chen, Y. Wang, K.J. Hatanpaa, J.A. Copland, R.J. DeBerardinis, Y. Wang, W. Luo, Targeting BCAT1 combined with \u03b1-ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Cancer Res. 82(13), 2388\u20132402 (2022)","journal-title":"Cancer Res."},{"issue":"6","key":"1003_CR38","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmet.2022.04.004","volume":"34","author":"C. Liu","year":"2022","unstructured":"C. Liu, W. Zou, D. Nie, S. Li, C. Duan, M. Zhou, P. Lai, S. Yang, S. Ji, Y. Li, M. Mei, S. Bao, Y. Jin, J. Pan, Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML. Cell. Metab. 34(6), 818\u2013835.e7 (2022)","journal-title":"Cell. Metab."},{"issue":"1","key":"1003_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00018-020-03483-1","volume":"78","author":"B. Zhang","year":"2021","unstructured":"B. Zhang, Y. Chen, X. Shi, M. Zhou, L. Bao, K.J. Hatanpaa, T. Patel, R.J. DeBerardinis, Y. Wang, W. Luo, Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Cell. Mol. Life Sci. CMLS 78(1), 195\u2013206 (2021)","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"8","key":"1003_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s42255-020-0226-5","volume":"2","author":"Z. Zhu","year":"2020","unstructured":"Z. Zhu, A. Achreja, N. Meurs, O. Animasahun, S. Owen, A. Mittal, P. Parikh, T.-W. Lo, J. Franco-Barraza, J. Shi, V. Gunchick, M.H. Sherman, E. Cukierman, A.M. Pickering, A. Maitra, V. Sahai, M.A. Morgan, S. Nagrath, T.S. Lawrence, D. Nagrath, Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. Nat. Metab. 2(8), 775\u2013792 (2020)","journal-title":"Nat. Metab."},{"issue":"9","key":"1003_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/leu.2016.98","volume":"30","author":"C. Tregnago","year":"2016","unstructured":"C. Tregnago, E. Manara, M. Zampini, V. Bisio, C. Borga, S. Bresolin, S. Aveic, G. Germano, G. Basso, M. Pigazzi, CREB engages C\/EBP\u03b4 to initiate leukemogenesis. Leukemia 30(9), 1887\u20131896 (2016)","journal-title":"Leukemia"},{"issue":"4","key":"1003_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","volume":"7","author":"D.B. Shankar","year":"2005","unstructured":"D.B. Shankar, J.C. Cheng, K. Kinjo, N. Federman, T.B. Moore, A. Gill, N.P. Rao, E.M. Landaw, K.M. Sakamoto, The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 7(4), 351\u2013362 (2005)","journal-title":"Cancer Cell."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-01003-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:03:15Z","timestamp":1744621395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-01003-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-01003-y","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"3 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee for Medical Research at Shanghai Jiao Tong University School of Medicine. Animal experiments were approved by our institutes and complied with the Guideline for Animal Care at the Shanghai Jiao Tong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}